InvestorsHub Logo
Followers 26
Posts 1237
Boards Moderated 0
Alias Born 06/30/2015

Re: None

Friday, 11/27/2015 9:38:59 PM

Friday, November 27, 2015 9:38:59 PM

Post# of 130743
About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us their word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares. Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report Q3, 2015

So, when Q3 10-Q is filed, we will see whether the share structure is reduced from 4.5 billion to the originally suggested 2.99 billion, more or less.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.